Key result
Concurrent use of terfenadine and ketoconazole was identified as a trigger for life-threatening torsades de pointes due to inhibition of terfenadine metabolism.
Case Report
Answers are grounded in this paper and cite their sources.
Highlights the critical importance of recognizing drug-drug interactions, specifically the historical identification of torsades de pointes risk with concurrent terfenadine and ketoconazole use.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
C. C. Peck (1993) conducted a case report in Torsades de pointes. Concurrent terfenadine and ketoconazole was evaluated on Torsades de pointes. Concurrent use of terfenadine and ketoconazole was identified as a trigger for life-threatening torsades de pointes due to inhibition of terfenadine metabolism.
Synapse has enriched 10 related papers. Consider them for comparative context: